Published in Blood on January 08, 2008
Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation. Blood (2009) 3.04
Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng (2010) 2.66
Hematopoietic stem cell mobilization: updated conceptual renditions. Leukemia (2012) 1.49
Current insights on the regenerative potential of the periosteum: molecular, cellular, and endogenous engineering approaches. J Orthop Res (2012) 1.21
Mesenchymal Stem Cells in Bone Regeneration. Adv Wound Care (New Rochelle) (2013) 1.18
Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms. Blood (2012) 1.14
Cell sources for bone tissue engineering: insights from basic science. Tissue Eng Part B Rev (2011) 1.10
Mesenchymal stem cell transplantation in multiple sclerosis. J Neurol Sci (2013) 1.04
Bone regeneration: stem cell therapies and clinical studies in orthopaedics and traumatology. J Cell Mol Med (2011) 1.03
Amelioration of a mouse model of osteogenesis imperfecta with hematopoietic stem cell transplantation: microcomputed tomography studies. Exp Hematol (2010) 0.99
Pathogen-free, plasma-poor platelet lysate and expansion of human mesenchymal stem cells. J Transl Med (2014) 0.94
Transplanted murine long-term repopulating hematopoietic cells can differentiate to osteoblasts in the marrow stem cell niche. Mol Ther (2013) 0.85
Osteopoietic engraftment after bone marrow transplantation: effect of inbred strain of mice. Exp Hematol (2010) 0.83
Non-hematopoietic stem cells in umbilical cord blood. Int J Stem Cells (2009) 0.81
Bone transplantation and tissue engineering, part IV. Mesenchymal stem cells: history in orthopedic surgery from Cohnheim and Goujon to the Nobel Prize of Yamanaka. Int Orthop (2015) 0.81
Hematopoietic stem cells give rise to osteo-chondrogenic cells. Blood Cells Mol Dis (2012) 0.81
Cytokine-induced osteopoietic differentiation of transplanted marrow cells. Blood (2011) 0.80
Osteogenic Differentiation of Periosteal Cells During Fracture Healing. J Cell Physiol (2016) 0.76
Further proof for an unpopular concept: a single cell from bone marrow can serve as a stem cell for both hematopoiesis and osteogenesis. Mol Ther (2013) 0.75
Osteopoietic stem cells: transplantable, but regeneratively limited. Blood (2008) 0.75
Osteoblastic cells regulate the haematopoietic stem cell niche. Nature (2003) 19.60
Identification of the haematopoietic stem cell niche and control of the niche size. Nature (2003) 18.17
Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med (1999) 9.73
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A (2002) 6.05
Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature (2005) 5.54
Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest (1998) 5.03
Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci U S A (1995) 4.47
The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs (2001) 4.31
The stem cell niches in bone. J Clin Invest (2006) 4.11
Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J Clin Invest (2001) 3.37
Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci U S A (1998) 3.17
Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates. Nat Med (2003) 2.91
Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res (2001) 2.89
Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J Bone Miner Res (1998) 2.72
Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood (2001) 2.65
Buried alive: how osteoblasts become osteocytes. Dev Dyn (2006) 2.23
Contribution of hematopoietic stem cells to skeletal muscle. Nat Med (2003) 2.18
Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation. Proc Natl Acad Sci U S A (2004) 1.82
Cells capable of bone production engraft from whole bone marrow transplants in nonablated mice. J Exp Med (1999) 1.51
Primitive adult hematopoietic stem cells can function as osteoblast precursors. Proc Natl Acad Sci U S A (2003) 1.47
Transgenic mice with pancellular enhanced green fluorescent protein expression in primitive hematopoietic cells and all blood cell progeny. Genesis (2005) 1.35
Marrow cell transplantation for infantile hypophosphatasia. J Bone Miner Res (2003) 1.31
Significant differences among skeletal muscles in the incorporation of bone marrow-derived cells. Dev Biol (2003) 1.29
Transplantable marrow osteoprogenitors engraft in discrete saturable sites in the marrow microenvironment. Exp Hematol (2008) 1.00
Transplanted hematopoietic cells seed in clusters in recipient bone marrow in vivo. Stem Cells (2002) 0.96
Prevention of senile osteoporosis in SAMP6 mice by intrabone marrow injection of allogeneic bone marrow cells. Stem Cells (2002) 0.94
Treatment of senile osteoporosis in SAMP6 mice by intra-bone marrow injection of allogeneic bone marrow cells. Stem Cells (2005) 0.93
Lifetime of the osteoblast in mouse periodontium. Anat Rec (1988) 0.93
Osteoprogenitor cells as targets for ex vivo gene transfer. J Bone Miner Res (1998) 0.91
Bone marrow stromal cells as a vehicle for gene transfer. Gene Ther (1999) 0.90
Radiation effects on bone. Radiology (1952) 0.79
Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy. J Clin Oncol (2010) 3.32
Pertuzumab monotherapy after trastuzumab-based treatment and subsequent reintroduction of trastuzumab: activity and tolerability in patients with advanced human epidermal growth factor receptor 2-positive breast cancer. J Clin Oncol (2012) 3.07
Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation. Blood (2009) 3.04
Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: results of the randomized phase II CHER-LOB study. J Clin Oncol (2012) 2.76
Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nat Med (2003) 2.61
Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation. Proc Natl Acad Sci U S A (2004) 1.82
Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs. Blood (2007) 1.77
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy. Cancer Res (2010) 1.64
Randomized phase III trial of ixabepilone plus capecitabine versus capecitabine in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. J Clin Oncol (2010) 1.59
A catalyst for change: the European cancer Patient's Bill of Rights. Oncologist (2014) 1.55
Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis. J Bone Miner Res (2003) 1.55
Parabiotic heterogenetic pairing of Abcc6-/-/Rag1-/- mice and their wild-type counterparts halts ectopic mineralization in a murine model of pseudoxanthoma elasticum. Am J Pathol (2010) 1.35
T-cell alloreactivity dominates natural killer cell alloreactivity in minimally T-cell-depleted HLA-non-identical paediatric bone marrow transplantation. Br J Haematol (2003) 1.34
"In vitro" and multicolor phenotypic characterization of cell subpopulations identified in fresh human adipose tissue stromal vascular fraction and in the derived mesenchymal stem cells. J Transl Med (2007) 1.29
Biweekly chemotherapy with oxaliplatin, irinotecan, infusional Fluorouracil, and leucovorin: a pilot study in patients with metastatic colorectal cancer. J Clin Oncol (2002) 1.27
Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers. Am J Cancer Res (2011) 1.18
Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms. Blood (2012) 1.14
Epidermal growth factor receptor (EGFR) high gene copy number and activating mutations in lung adenocarcinomas are not consistently accompanied by positivity for EGFR protein by standard immunohistochemistry. J Mol Diagn (2008) 1.11
Obesity in patients with acute lymphoblastic leukemia in childhood. Ital J Pediatr (2012) 1.09
Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning. Blood (2013) 1.07
Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients. Transplantation (2006) 1.06
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies. J Clin Invest (2016) 1.05
Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies. Breast Cancer Res Treat (2010) 1.03
Cochlear implantation for unilateral deafness with and without tinnitus: a case series. Laryngoscope (2013) 1.03
Impact of floating mass transducer coupling and positioning in round window vibroplasty. Otol Neurotol (2011) 1.02
The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemia. Cytotherapy (2009) 1.01
Transplantable marrow osteoprogenitors engraft in discrete saturable sites in the marrow microenvironment. Exp Hematol (2008) 1.00
International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010). J Natl Cancer Inst Monogr (2011) 1.00
Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet. Transplantation (2002) 1.00
Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies. Br J Haematol (2006) 0.99
Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs. Clin Pharmacokinet (2002) 0.99
Gene expression profiling in breast cancer: a clinical perspective. Breast (2013) 0.99
Phase II study of a protracted irinotecan schedule in children with refractory or recurrent soft tissue sarcoma. Cancer (2006) 0.98
Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer. Expert Opin Pharmacother (2012) 0.97
Posterior reversible encephalopathy syndrome during ipilimumab therapy for malignant melanoma. J Clin Oncol (2011) 0.96
Heterogeneity of multipotent mesenchymal stromal cells: from stromal cells to stem cells and vice versa. Transplantation (2009) 0.96
GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion. Cytotherapy (2010) 0.95
Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondria. Pathol Oncol Res (2006) 0.95
Tendon progenitor cells in injured tendons have strong chondrogenic potential: the CD105-negative subpopulation induces chondrogenic degeneration. Stem Cells (2014) 0.95
A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer. Breast Cancer Res Treat (2013) 0.94
Leukemia risk in children exposed to benzene and PM10 from vehicular traffic: a case-control study in an Italian population. Eur J Epidemiol (2012) 0.93
Malignant infantile osteopetrosis and primary pulmonary hypertension: a new combination? Pediatr Blood Cancer (2004) 0.93
Manufacturing mesenchymal stromal cells for phase I clinical trials. Cytotherapy (2013) 0.93
Skeletons in the p53 tumor suppressor closet: genetic evidence that p53 blocks bone differentiation and development. J Cell Biol (2006) 0.91
Clinical outcomes following hematopoietic stem cell transplantation for the treatment of mucopolysaccharidosis VI. Mol Genet Metab (2010) 0.91
Relapsed triple-negative breast cancer: challenges and treatment strategies. Drugs (2013) 0.91
Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood. Biomed Res Int (2013) 0.89
The European paediatric legislation: benefits and perspectives. Ital J Pediatr (2010) 0.89
MSC and Tumors: Homing, Differentiation, and Secretion Influence Therapeutic Potential. Adv Biochem Eng Biotechnol (2013) 0.89
The impact of cochlear implantation on speech understanding, subjective hearing performance, and tinnitus perception in patients with unilateral severe to profound hearing loss. Otol Neurotol (2015) 0.88
Cell therapy for disorders of bone. Cytotherapy (2009) 0.88
Q-TWiST analysis of ixabepilone in combination with capecitabine on quality of life in patients with metastatic breast cancer. Cancer (2011) 0.88
Mesenchymal stromal/stem cells markers in the human bone marrow. Cytotherapy (2013) 0.88
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. J Clin Pathol (2012) 0.87
Non-invasive methods can predict oesophageal varices in patients with biliary atresia after a Kasai procedure. Dig Liver Dis (2011) 0.86
Risk of hematological malignancies associated with magnetic fields exposure from power lines: a case-control study in two municipalities of northern Italy. Environ Health (2010) 0.86
Etiology and outcome of graft failure in pediatric hematopoietic stem cell transplant recipients. J Pediatr Hematol Oncol (2003) 0.85
Rituximab induces different but overlapping sets of genes in human B-lymphoma cell lines. Cancer Immunol Immunother (2004) 0.85
Transplanted murine long-term repopulating hematopoietic cells can differentiate to osteoblasts in the marrow stem cell niche. Mol Ther (2013) 0.85
Population pharmacokinetics of trastuzumab emtansine (T-DM1), a HER2-targeted antibody-drug conjugate, in patients with HER2-positive metastatic breast cancer: clinical implications of the effect of covariates. Cancer Chemother Pharmacol (2014) 0.84
Two consecutive immunophenotypic switches in a child with MLL-rearranged acute lymphoblastic leukemia. Haematologica (2006) 0.84
Survival in patients with newly diagnosed conventional glioblastoma: a modified prognostic score based on a single-institution series. Tumori (2012) 0.84
Mesenchymal progenitors aging highlights a miR-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis. Stem Cells (2015) 0.84
Adipose stromal/stem cells assist fat transplantation reducing necrosis and increasing graft performance. Apoptosis (2013) 0.83
Plasma levels of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in patients with neuroblastoma. Int J Cancer (2006) 0.83
Pediatric pharmacogenetic and pharmacogenomic studies: the current state and future perspectives. Eur J Clin Pharmacol (2010) 0.83
Improved isolation and expansion of bone marrow mesenchymal stromal cells using a novel marrow filter device. Cytotherapy (2012) 0.83
Intellectual function evaluation of first generation immigrant children with sickle cell disease: the role of language and sociodemographic factors. Ital J Pediatr (2013) 0.83
Osteopoietic engraftment after bone marrow transplantation: effect of inbred strain of mice. Exp Hematol (2010) 0.83